Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Lip

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Ophthalmology|April 12, 2001
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunctionP L Lip, A D Blann, M Hope-Ross, et al.
The British Journal of Ophthalmology|June 21, 2005
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatmentJ S Mohan, P L Lip, A D Blann, et al.
Journal of Hypertension|December 1, 1995
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary reportG Y Lip, A D Blann, J Zarifis, et al.
Acta Ophthalmologica Scandinavica|November 24, 1998
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?P L Lip, A F Jones, N Price, et al.
International Journal of Clinical Practice|February 15, 2011
Peri-operative management of ophthalmic patients taking antithrombotic therapyG Y H Lip, O M Durrani, V Roldan, et al.
Investigative Ophthalmology & Visual Science|July 13, 2000
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatmentP L Lip, F Belgore, A D Blann, et al.
Circulation|August 1, 1996
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirinG Y Lip, P L Lip, J Zarifis, et al.
Eye (London, England)|November 4, 2017
Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world resultP L Lip, P Cikatricis, A Sarmad, et al.
The British Journal of Ophthalmology|November 19, 2004
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockadeP L Lip, S Chatterjee, G J Caine, et al.
The British Journal of Ophthalmology|October 19, 2002
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucomaP L Lip, D C Felmeden, A D Blann, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Ophthalmology|April 12, 2001
Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunctionP L Lip, A D Blann, M Hope-Ross, et al.
The British Journal of Ophthalmology|June 21, 2005
The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatmentJ S Mohan, P L Lip, A D Blann, et al.
Journal of Hypertension|December 1, 1995
Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary reportG Y Lip, A D Blann, J Zarifis, et al.
Acta Ophthalmologica Scandinavica|November 24, 1998
Do intraocular angiotensin II levels, plasma prothrombotic factors and endothelial dysfunction contribute to proliferative diabetic retinopathy?P L Lip, A F Jones, N Price, et al.
International Journal of Clinical Practice|February 15, 2011
Peri-operative management of ophthalmic patients taking antithrombotic therapyG Y H Lip, O M Durrani, V Roldan, et al.
Investigative Ophthalmology & Visual Science|July 13, 2000
Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatmentP L Lip, F Belgore, A D Blann, et al.
Circulation|August 1, 1996
Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirinG Y Lip, P L Lip, J Zarifis, et al.
Eye (London, England)|November 4, 2017
Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world resultP L Lip, P Cikatricis, A Sarmad, et al.
The British Journal of Ophthalmology|November 19, 2004
Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockadeP L Lip, S Chatterjee, G J Caine, et al.
The British Journal of Ophthalmology|October 19, 2002
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucomaP L Lip, D C Felmeden, A D Blann, et al.
Pageof 3